Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Xiang‐Lin Tan

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100856608. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper

Papers 9

  1. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis. Last author DOI 10.2174/0929867324666170412145232↗
  2. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study. Last author DOI 10.1158/1055-9965.epi-17-0227↗
  3. In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cells. Last author DOI 10.1038/srep31672↗
  4. Targeting tumor-associated macrophages to combat pancreatic cancer. Last author DOI 10.18632/oncotarget.9383↗
  5. Transcriptomic analysis of pancreatic cancer cells in response to metformin and aspirin: an implication of synergy. Last author DOI 10.1038/srep13390↗
  6. Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2. Last author DOI 10.18632/oncotarget.4126↗
  7. Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment. Last author DOI 10.1158/1940-6207.capr-13-0337↗
  8. Polymorphisms in metabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk. Co-author DOI 10.1097/mpa.0b013e3182968e00↗
  9. Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen, and pancreatic cancer risk: a clinic-based case-control study. Co-author DOI 10.1158/1940-6207.capr-11-0146↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wen Yue · 5 shared papers, 2014–2016 · strength 0.30
  2. E Jian‐Yu · 3 shared papers, 2016–2018 · strength 0.23
  3. Qing Xu · 3 shared papers, 2015–2016 · strength 0.17
  4. Gloria M. Petersen · 3 shared papers, 2011–2017 · strength 0.13
  5. Ran Cui · 1 shared paper, 2016 · strength 0.07
  6. Feng Xu · 1 shared paper, 2016 · strength 0.06
  7. JingJing Duan · 1 shared paper, 2016 · strength 0.06
  8. Kristin E. Anderson · 2 shared papers, 2011–2013 · strength 0.06
  9. Ann L. Oberg · 2 shared papers, 2011–2013 · strength 0.06
  10. Xi Zheng · 1 shared paper, 2015 · strength 0.05
  11. Darren R. Carpizo · 1 shared paper, 2015 · strength 0.05
  12. Rashmi R. Sinha · 1 shared paper, 2013 · strength 0.03
  13. Kari G. Rabe · 1 shared paper, 2013 · strength 0.03
  14. Rachael Z. Stolzenberg‐Solomon · 1 shared paper, 2013 · strength 0.03
  15. Rick J. Jansen · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.